Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lupus nephritis.

Neerja Agrawal1, Lo-Ku Chiang, Ian R Rifkin

  • 1Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Seminars in Nephrology
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting Simultaneous Liver and Kidney Transplantation from Donors After Circulatory Death in the Era of Machine Perfusion Technologies: A US Nationwide Analysis of 10,687 Cases.

Annals of surgery·2026
Same author

Impact of Normothermic Regional Perfusion on Clinical Outcomes in Kidney Transplantation From Donors After Circulatory Death: A US Nationwide Analysis of 38,048 Cases.

Annals of surgery·2026
Same author

The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.

bioRxiv : the preprint server for biology·2025
Same author

Incremental hemodialysis transition in veterans and nonveterans with kidney failure.

Current opinion in nephrology and hypertension·2024
Same author

Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways.

Journal of immunology (Baltimore, Md. : 1950)·2023
Same author

EGF-Receptor-Dependent TLR7 Signaling in Macrophages Promotes Glomerular Injury in Crescentic Glomerulonephritis.

Laboratory investigation; a journal of technical methods and pathology·2023

Lupus nephritis, a severe complication of systemic lupus erythematosus, presents treatment challenges. Emerging therapies, informed by basic science, aim for safer and more targeted approaches to manage this autoimmune kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Rheumatology

Background:

  • Lupus nephritis is a serious manifestation of systemic lupus erythematosus (SLE), leading to significant morbidity and mortality.
  • Current treatments for lupus nephritis face challenges in balancing disease control with therapy side effects.
  • The precise etiology and pathogenesis of SLE and lupus nephritis are not fully understood.

Purpose of the Study:

  • To review the current understanding and treatment of lupus nephritis.
  • To highlight the translation of basic science research into novel therapeutic strategies for lupus nephritis.
  • To discuss the potential for safer and more specific treatments for this condition.

Main Methods:

  • Review of recent clinical trials defining optimal immunosuppressive regimens.

Related Experiment Videos

  • Analysis of basic science research findings in animal models and human studies.
  • Synthesis of current knowledge on lupus nephritis etiology, pathogenesis, and treatment.

    • Main Results:

    • Clinical trials are refining optimal immunosuppressive regimens for lupus nephritis.
    • Basic science research is providing insights into the underlying mechanisms of SLE and lupus nephritis.
    • Newer therapies with potential for improved safety and specificity are emerging.

    Conclusions:

    • Treatment of lupus nephritis remains complex, requiring careful management of immunosuppression.
    • Advancements in understanding SLE and lupus nephritis pathogenesis are paving the way for innovative treatments.
    • Future therapies hold promise for more effective and targeted management of lupus nephritis, reducing patient morbidity and mortality.